Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9640-9649

  Richardson, J ^a   Moraillon, A ^b   Baud, S ^a   Cuisinier, A M ^c   Sonigo, P ^a   Pancino, G ^a  

^a INSTITUT COCHIN   (France)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c Virbac SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; VIRUS DNA;

ARTICLE; CAT; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; IMMUNIZATION; IMMUNOASSAY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS ISOLATION;

EID: 0030830867     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9640-9649.1997     Document Type: Article

References (81)

1. Akolkar, P. N., B. Gulwani-Akolkar, N. Chirmule, S. Pahwa, V. S. Kalyanaraman, R. Pergolizzi, S. Macphail, and J. Silver. 1995. The HIV glycoprotein gp160 has superantigen-like properties. Clin. Immunol. Immunopathol. 76:255-265.
2. Avraméas, A., A. D. Strosberg, A. Moraillon, P. Sonigo, and G. Pancino. 1993. Serological diagnosis of feline immunodeficiency virus (FIV) infection based on synthetic peptides from Env glycoproteins. Res. Virol. 144:209-218.
3. Bach, J.-M., M. Hurtrel, L. Chakrabarti, J.-P. Ganière, L. Montagnier, and B. Hurtrel. 1994. Early stages of feline immunodeficiency virus infection in lymph nodes and spleen. AIDS Res. Hum. Retroviruses 10:1731-1738.
4. Beebe, A. M., N. Dua, T. G. Faith, P. Moore, N. Pedersen, and S. Dandekar. 1994. Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J. Virol. 68:3080-3091.
5. Bendinelli, M, M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi, and F. Tozzini. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8:87-112.
6. Berberian, L., L. Goodlick, T. J. Kipps, and J. Braun. 1993. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261:1588-1591.
7. Bertoni, G., M.-L. Zahno, R. Zanoni, H.-R. Vogt, E. Peterhans, G. Ruff, W. P. Cheevers, P. Sonigo, and G. Pancino. 1994. Antibody reactivity to the immunodominant epitopes of the caprine arthritis-encephalitis virus gp38 transmembrane glycoprotein associates with the development of arthritis. J. Virol. 68:7139-7147.
8. Broder, C. C., P. L. Earl, D. Long, S. T. Abedon, B. Moss, and R. W. Doms. 1994. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. Proc. Natl. Acad. Sci. USA 91:11699-11703.
9. Cohen, J. 1993. Jitters jeopardize AIDS vaccine trials. Science 262:980-981.
10. Davis, H. L., R. G. Whalen, and B. A. Demeneix. 1993. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4:151-159.
11. Dawson, J. D. 1994. Comparing treatment groups on the basis of slopes, areas-under-the-curve, and other summary measures. Drug Inf. J. 28:723-732.
12. Diehl, L. J., C. K. Mathiason-DuBard, L. O'Neil, and E. A. Hoover. 1995. Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J. Virol. 69:2328-2332.
13. Dobrescu, D., S. Kabak, K. Mehta, C. H. Suh, A. Asch, P. U. Cameron, A. S. Hodtsev, and D. N. Posnett. 1995. Human immunodeficiency virus 1 reservoir in CD4+ T cells is restricted to certain Vβ subsets. Proc. Natl. Acad. Sci. USA 92:5563-5567.
14. Earl, P. L., C. C. Broder, D. Long, S. A. Lee, J. Peterson, S. Chakrabarti, R. W. Doms, and B. Moss. 1994. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68:3015-3026.
15. Eaton, A. M., K. E. Ugen, D. B. Weiner, T. Wildes, and J. A. Levy. 1994. An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement. AIDS Res. Hum. Retroviruses 10:13-18.
16. English, R. V., J. C. M., D. H. Gebhard, and M. B. Tomkins. 1993 In vivo lymphocyte tropism of feline immunodeficiency virus. J. Virol. 67:5175-5186.
17. Flynn, J. N., M. J. Hosie, C. A. Cannon, M. A. Rigby, A. H. Mackay, D. A. Argyle, T. Miyazawa, O. Jarret, D. E. Onions, and J. C. Neil. 1997. FIV, SIV and SHIV vaccination, p. 60. Fondation Marcel Merieux, Annecy, France.
18. Fuller, D. H., M. Murphey-Corb, J. Clements, S. Barnett, and J. R. Haynes. 1996. Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J. Med. Primatol. 25:236-241.
19. Fust, G., F. D. Toth, J. Kiss, E. Ujhelyi, I. Nagy, and D. Banhegi. 1994. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1 infected individuals correlate with immunosuppression and disease. AIDS 8:603-609.
20. Goff, S., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
21. Guiot, A. L., D. Rigal, D. Pialot, and G. Chappuis. 1995. Development of a simple, rapid and accurate in vitro whole blood technique for the detection and semi-quantification of FIV cellular viremia. Vet. Microbiol. 47:331-342.
22. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carrol, L. C. Yang, S. Goldstein, M. Piatak, Jr., V. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus ankara. J. Virol. 70:3741-3752.
23. Ho, D. D., M. S. C. Fung, H. Yoshiyama, Y. Cao, and J. E. Robinson. 1992. Discontinuous epitopes on gp120 important in HIV-1 neutralization. AIDS Res. Hum. Retroviruses 8:1337-1339.
24. Homsy, J., M. Meyer, and J. A. Levy. 1990. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J. Virol. 64:1437-1440.
25. Homsy, J., M. Meyer, M. Tateno, S. Clarkson, and J. A. Levy. 1989. The Fc and Not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244:1357-1360.
26. Hosie, M. J., T. H. Dunsford, A. De Ronde, B. J. Willett, C. A. Cannon, J. C. Neil, and O. Jarrett. 1996. Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine 14:405-411.
27. Imberti, L., A. Sottini, A. Bettinardi, M. Puoti, and D. Primi. 1991. Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 254:860-862.
28. Issel, C. J., D. W. Horobov, D. F. Lea, W. V. Adams, S. D. Hagras, J. M. McManus, A. C. Allison, and R. C. Montelaro. 1992. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 66:3398-3408.
29. Knowles, D., W. Cheevers, T. McGuire, T. Stem, and J. Gorham. 1990. Severity of arthritis is predicted by antibody response Io gp135 in chronic infection with caprine arthritis-encephalitis virus. J. Virol. 64:2396-2398.
30. Kostrikis, L. G., Y. Cao, H. Ngai, J. P. Moore, and D. D. Ho. 1996. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E. F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J. Virol. 70:445-458.
31. Lu, S., J. Arthos, D. C. Motefiori, Y. Yasutomi, K. Manson, F. Mustafa, E. Johnson, J. C. Santoro, J. Wissink, J. I. Mullins, J. R. Haynes, N. L. Lervin, M. Wyand, and H. L. Robinson. 1996. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70:3978-3991.
32. Lu, S., J. C. Santoro, D. H. Fuller, J. R. Haynes, and H. L. Robinson. 1995. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209:147-154.
33. Lund, O., J. Hansen, E. Mosekilde, J. O. Nielsen, and J.-E. S. Hansen. 1993. A model of enhancement and inhibition of monocytes by antibodies against HIV. J. Biol. Phys. 19:133-145.
34. Lutz, H., R. Hoffmann-Lehmann, K. Bauer-Pham, E. Holznagel, F. Tozzini, M. Bendinelli, G. Reubel, A. Aubert, D. Davis, D. Cox, and E. Young. 1995. FIV vaccine. I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Vet. Immunol. 46:115-125.
35. Mascola, J. R., B. J. Mathieson, P. M. Zack, M. C. Walker, S. B. Halstead, and D. S. Burke. 1993. Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res. Hum. Retroviruses 9:1175-1184.
36. McElrath, M. J., L. Corey, G. P. D., T. J. Matthews, D. C. Montefiori, L. Rowen, L. Hood, and J. I. Mullins. 1996. Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen. Proc. Natl. Acad. Sci. USA 93:3972-3977.
37. McGuire, T. C., D. P. Knowles, W. C. Davis, A. L. Brassfield. T. A. Stem, and W. P. Cheevers. 1992. Transmembrane protein oligomers of caprine arthritis-encephalitis lentivirus are immunodominant in goats with progressive arthritis. J. Virol. 66:3274-3250.
38. Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas III, D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp 120, and their neutralization is not predicted by studies with monomeric gp 120. J. Virol. 69:101-109.
39. Moore, J. P., and D. D. Ho. 1995. HIV neutralization: the consequence of viral adaptation to growth on transformed T cells. AIDS. 9(Suppl. A):S117-S136.
40. Moraillon, A., F. Barre-Sinoussi, A. Parodi, R. Moraillon, and C. Dauguet 1992. In vitro properties and experimental pathogenic effect of three feline immunodeficiency viruses (FIV) isolated from cats with terminal disease. Vet. Microbiol. 31:41-54.
41. Moraillon, A., J. Richardson, and G. Pancino. Unpublished data.
42. Nara, P. L., R. R. Garrity, and J. Goudsmit. 1991. Neutralization of HIV-1: a paradox of humoral proportions. FASEB J. 5:2437-2455.
43. O'Brien, W. A., K. Grovit-Ferbas, A. Namazi, S. Ovcak-Derzic, H.-J. Wang, J. Park, C. Yeramian, S.-H. Mao, and J. A. Zack. 1995. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86:1082-1089.
44. Okuda, K., H. Bukawa, K. Hamajima, S. Kawamoto, K.-I. Sekigawa, Y. Yamada, S.-I. Tanaka, N. Ishi, I. Aoki, M. Nakamura, H. Yamamoto, B. R. Cullen, and J. Fukushima. 1995. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res. Hum. Retroviruses 11:933-942.
45. Pancino, G., L. Camoin, and P. Sonigo. 1995. Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J. Virol. 69:2110-2118.
46. Pancino, G., S. Castelot, and P. Sonigo. 1995. Differences in feline immunodeficiency vinis (FIV) host cell range correlate with envelope fusoproperties. Virology 206:796-806.
47. Pancino, G, C. Chappey, W. Saurin, and P. Sonigo. 1993. B epitopes and selection pressures in feline immunodeficiency virus envelope gtycoproteins. J. Virol. 67:664-672.
48. Pancino, G., I. Fossati, C. Chappey, S. Castelct, B. Hurtrel, A. Moraillon, D. Klatzmann, and P. Sonigo. 1993. Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology 192:659-662.
49. Pancino, G., and P. Sonigo. 1997. Retention of viral infectivity after extensive mutation of the highly conserved immunodominant domain of the feline immunodeficiency virus envelope. J. Virol. 71:4339-4346.
50. Pardoll, D. M., and A. M. Beckerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165-169.
51. Pertmer, T. M., T. R. Roberts, and J. R. Haynes. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector delivery. J. Virol. 70:6119-6125.
52. Piatak, M. J, K.-C. Luk, B. Williams, and J. D. Lifson. 1993. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. BioTechniques 14:70-80.
53. Pistello, M., S. Menzo, M. Giorgi, L. Da Prato, G. Cammarota, M. Clementi, and M. Bendinelli. 1994. Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol. Cell. Probes 8:229-234.
54. Poignard, P., P. J. Klasse, and Q. J. Sattentau. 1996. Neutralization of the human immunodeficiency virus type 1. Immunol. Today 17:239-246.
55. Reid, G., M. A. Rigny, M. McDonald, M. J. Hosie, J. C. Neil, and O. Jarrett. 1991. Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS 5:1477-1483.
56. Richardson, J., I. Fossati, A. Moraillon, S. Castelot, P. Sonigo, and G. Pancino. 1996. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope. J. Gen. Virol. 77:759-771.
57. Robinson, W. E., M. K. Gorny, J. I. Xy, W. M. Mitchell, and S. Zolla-Pazner. 1991. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J. Virol. 65:4169-4176.
58. Robinson, W. E., T. Kawamura, D. Lake, Y. Masuho, W. M. Mitchell, and E. M. Hersh. 1990. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 enhance HIV-1 infection in vitro. J. Virol. 64:5301-5305.
59. Robinson, W. E., D. C. Montefiori, and W. M. Mitchell. 1988. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet i:790-794.
60. Robinson, W. E., D. C. Montefiori, and W. M. Mitchell. 1987. A human immunodeficiency virus infection-enhancing factor in seropositive sera. Biochem. Biophys. Res. Commun. 149:693-699.
61. Robinson, W. E., D. C. Montefiori, W. M. Mitchell, A. M. Prince, H. J. Alter, G. R. Dreesman, and J. W. Eichberg. 1989. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc. Natl. Acad. Sci. USA 86:4710-4714.
62. Sattentau, Q. J., S. Zolla-Pazner, and P. Poignard. 1995. Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 206:713-717.
63. Schutten, M., A. C. Andeweg, M. L. Bosch, and A. D. M. E. Osterhaus. 1995. Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1. Scand. J. Immunol. 41:18-22.
64. Schwartz, D. H. 1994. Potential pitfalls on the road to an effective HIV vaccine. Immunol. Today 15:54-57.
65. Siebelink, K. H. J., E. Tijhaar, R. C. Huisman, W. Huisman, A. de Ronde, I. H. Darby, M. J. Francis, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 1995. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 69:3704-3711.
66. Stanley, S. K., M. A. Ostrowski, J. S. Justement, K. Gantt, S. Hedayati. M. Mannix, K. Roche, D. J. Schwartzentruber, C. H. Fox, and A. S. Fauci. 1996. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N. Engl. J. Med. 334:1222-1230.
67. Steele, F. R. 1995. gp120: Good, bad or indifferent. Nat. Med. 1:1105-1106.
68. Steimer, K. S., C. J. Scandella, P. V. Stiles, and N. L. Haigwood. 1991. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science 254:105-108.
69. Sullivan, N., Y. Sun, J. Li, W. Hofman, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
70. Takeda, A., J. E. Robinson, D. D. Ho, C. Debouck, N. L. Haigwood, and F. Ennis. 1992. Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120. J. Clin. Invest. 89:1952-1957.
71. Takeda, A., C. U. Tuazon, and F. A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via FC receptor-mediated entry. Science 242:580-583.
72. Talbott, R. L., E. E. Sparger, K. M. Lovelace, W. M. Fitch, N. C. Pedersen, P. A. Luciw, and J. H. Elder. 1989. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:5743-5747.
73. Wang, B., J. Boyer, V. Srikantan, K. Ugen, L. Gilbert, C. Phan, K. Dang, M. Merva, M. G. Agadjanvan, M. Newman, R. Carrano, D. McCallus, L. Coney, W. V. Williams, and D. B. Weiner. 1995. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in non human primates by in vivo DNA inoculation. Virology 211:102-112.
74. Wang, B., K. E. Ugen, V. Srikantan, M. Agadjanyan, K. Dang, Y. Refaeli, A. Sato, J. Boyer, W. Williams, and W. D. B. 1993. Gene inoculation generates immune responses against human immunodificiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156-4160.
75. Wang, S Z.-S., K. E. Rushlow, C. J. Issel, R. F. Cook, S. J. Cook, M. L. Raabe, Y.-H. Chong, L. Costa, and R. C. Montelaro. 1994. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombmant envelope surface glycoprotein. Virology 199:247-251.
76. Watson A., J. Ranchalis, B. Travis, M. J., W. Sutton, P. R. Johnson, S. L. Hu, and N. L. Haigwood. 1997. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71:284-290.
77. Westby, M., F. Manca, and A. G. Dalgleish. 1996. The role of host immune responses in determining the outcome of HIV infection. Immunol. Today 17:120-125.
78. Wolff, J. O., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
79. Yamamoto, J. K., C. D. Ackley, H. Zochlinski, H. Louie, E. Pembroke, M. Torten, H. Hansen, R. Munn, and T. Okuda. 1991. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: Importance for diagnostic reagents and vaccines. Intervirology 32:361-375.
80. Zack, J. A., S. J. Arrigo, S. R. Weitzman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
81. Zagury, D., J. Bernard, R. Leonard, R. Cheynier, M. Feldman, P. S. Sarin, and R. C. Gallo. 1986. Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 231:850-853.